Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
January 6, 2006
By: Tim Wright
Editor-in-Chief, Contract Pharma
Genentech has promoted three senior vice presidents, Ian T. Clark, commercial operations, David Ebersman, chief financial officer, and Patrick Yang, Ph.D., product operations, to executive vice president. All three will continue to serve on the company’s executive committee and will report to chairman and chief executive officer, Arthur D. Levinson, Ph.D. Mr. Clark is responsible for leading the company’s commercial operations, including sales, marketing, managed care, and commercial development. He joined Genentech in January 2003 as senior vice president and general manager, BioOncology. Prior to joining the company, he served as president, Novartis Canada and also served as chief operating officer for Novartis UK. Prior to joining Novartis in 1999, he worked in positions of increasing strategic importance in sales, marketing and business development at Ivax Pharma and Sanofi-Synthelabo in the UK. Mr. Ebersman is responsible for Genentech’s finance, corporate relations, investor relations and corporate information technology groups. He joined the company in 1994 and previously held several positions in business development and product development. He was named senior director of product development in 1998, vice president of product development in 1999 and senior vice president of product operations in 2001. Before joining the company, he served as a research analyst covering biotechnology investments at Oppenheimer & Company, Inc. (now CIBC World Markets). Mr. Yang is responsible for the company’s manufacturing, engineering, process development and supply chain management organizations. He joined Genentech in December 2003 from Merck & Co., where he worked for 11 years and held several leadership roles in the manufacturing division. Most recently, he held the position of vice president, supply chain management. In this role, he led the materials management, strategic planning and manufacturing support functions for Merck’s worldwide manufacturing plants. Prior to that, he was Merck’s vice president, Asia/Pacific manufacturing operations.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !